These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13519558)

  • 1. [Changes in the transaminase activity of neoplastic tissue & in the hemopoietic tissue of myeloma-bearing rats during the leukemic phase following treatment with sarcochlorine].
    VIOLANTE A; LORENZUTTI G; RAGNI A
    Tumori; 1957; 43(5):644-7. PubMed ID: 13519558
    [No Abstract]   [Full Text] [Related]  

  • 2. On the conversion of 3-hydroxyanthranilic acid to quinolinic acid in presence of hepatic tissue of rats affected by Oberling's myeloma in the leukemic phase.
    QUAGLIARIELLO E; AURICCHIO S; RINALDI E; VIOLANTE A
    Clin Chim Acta; 1958 Jul; 3(4):381-3. PubMed ID: 13561506
    [No Abstract]   [Full Text] [Related]  

  • 3. Colony growth and self renewal of plasma cell precursors in multiple myeloma.
    Takahashi T; Lim B; Jamal N; Tritchler D; Lockwood G; McKinney S; Bergsagel DE; Messner HA
    J Clin Oncol; 1985 Dec; 3(12):1613-23. PubMed ID: 4067612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features.
    Schmidt-Hieber M; Pérez-Andrés M; Paiva B; Flores-Montero J; Perez JJ; Gutierrez NC; Vidriales MB; Matarraz S; San Miguel JF; Orfao A
    Haematologica; 2011 Feb; 96(2):328-32. PubMed ID: 20971816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma; lesions of the extra-osseous hematopoietic system.
    CHURG J; GORDON AJ
    Am J Clin Pathol; 1950 Oct; 20(10):934-45. PubMed ID: 14771016
    [No Abstract]   [Full Text] [Related]  

  • 6. Myeloma proteins and macroglobulins associated with plasma cell tumors in experimental animals.
    FAHEY JL; POTTER M; NATHANS D
    Acta Unio Int Contra Cancrum; 1960; 16():1137-40. PubMed ID: 13821297
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disorders of calcium and phosphate metabolism in multiple myeloma].
    SCHMUZIGER P; FLURY R
    Schweiz Med Wochenschr; 1962 Sep; 92():1085-90. PubMed ID: 13908868
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteins in multiple myeloma. IV. Interaction with metabolic nitrogen.
    HARDY S; PUTNAM FW
    J Biol Chem; 1955 Jan; 212(1):371-8. PubMed ID: 13233239
    [No Abstract]   [Full Text] [Related]  

  • 9. Turnover of labeled normal gamma globulin in multiple myeloma.
    LIPPINCOTT SW; KORMAN S; FONG C; STICKLEY E; WOLINS W; HUGHES WL
    J Clin Invest; 1960 Apr; 39(4):565-72. PubMed ID: 14417400
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteins in multiple myeloma. VIII. Biosynthesis of abnormal proteins.
    PUTNAM FW; MIYAKE A
    J Biol Chem; 1958 Apr; 231(2):671-84. PubMed ID: 13539002
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aspects of iron metabolism in multiple myeloma, examined with radioactive iron].
    FRANCKE C; HARDERS CL; VAN MULKEN JM; ROBERT WN
    Ned Tijdschr Geneeskd; 1954 Nov; 98(47):3377-83. PubMed ID: 13223880
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrophoretic research on the plasmatic and urinary proteins in multiple myeloma].
    GASTALDI F; RODARI T; CERESA G
    Rass Fisiopatol Clin Ter; 1961 Jul; 33():551-72. PubMed ID: 13897203
    [No Abstract]   [Full Text] [Related]  

  • 13. F Fate of radiosulfate in multiple myeloma.
    SIEGEL E; SACHS BA; GRAIG FA
    Proc Soc Exp Biol Med; 1959 May; 101(1):53-6. PubMed ID: 13658188
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytostatic effect of bis-(beta-chloroethyl)p-aminophenylalanine in Oberling myeloma-bearing rats].
    VIOLANTE A; LORENZUTTI G; RAGNI A
    Tumori; 1957; 43(6):739-52. PubMed ID: 13519563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathological protein synthesis in myeloma. (Chemical, chemico-physical and immunological aspects)].
    MAIORCA R; SCARPIONI L
    Rass Fisiopatol Clin Ter; 1960 Dec; 32():1173-225. PubMed ID: 13765490
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).
    BERGSAGEL DE; SPRAGUE CC; AUSTIN C; GRIFFITH KM
    Cancer Chemother Rep; 1962 Aug; 21():87-99. PubMed ID: 13867794
    [No Abstract]   [Full Text] [Related]  

  • 17. Aberrations of protein metabolism in multiple myeloma; interrelationships of abnormal serum globulins and Bence-Jones proteins.
    PUTNAM FW
    Physiol Rev; 1957 Oct; 37(4):512-38. PubMed ID: 13484474
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of M protein by mouse myeloma tumor: correlation of in vitro and in vivo methods.
    TRUAX WE; BRAY JP
    Blood; 1961 Aug; 18():176-81. PubMed ID: 13778228
    [No Abstract]   [Full Text] [Related]  

  • 19. Turnover rate of myeloma proteins in serum and urine determined after intravital labelling with glycine--1--C--14.
    DRIVSHOLM A
    Acta Med Scand; 1961 May; 169():503-7. PubMed ID: 13724428
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteins in multiple myeloma. III. Origin of Bence-Jones protein.
    PUTNAM FW; HARDY S
    J Biol Chem; 1955 Jan; 212(1):361-9. PubMed ID: 13233238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.